# Junta clínica — PT-pseudo_fc6cf5262222 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_fc6cf5262222",
  "pid": "PT-pseudo_fc6cf5262222",
  "task": 1,
  "psa": 7.5,
  "age": 61,
  "months": 1,
  "pirads": "4",
  "psad": 0.179,
  "psav": 1.49,
  "psap": 4.6,
  "vol": 42.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.0,
  "medhx": "Hypertension",
  "meds": "valsartan, metoprolol",
  "notes": "PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.",
  "pmhx": [
    "Hypertension"
  ],
  "allergies": [],
  "vitals": {
    "weight": "79 kg",
    "height": "177 cm",
    "bmi": "25.2",
    "bp": "124/76 mmHg",
    "hr": "83 bpm",
    "smoking": "Ex-smoker (34 pack-yr, quit 2006)",
    "last_dental": "3 yr ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Feb 2025",
  "enc_ref": "Dr. R. Visser (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive."
    },
    {
      "s": "History",
      "t": "A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.\nGeneral assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement."
    }
  ],
  "occupation": "self-employed contractor (carpentry)",
  "marital": "Married",
  "living": "Lives alone; adult son nearby",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "6 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Erasmus MC",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_fc6cf5262222
Task: 1

Encounter: Urology - outpatient on 22 Feb 2025.
Referrer: Dr. R. Visser (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 61-year-old male
  - PSA: 7.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.179 ng/mL²
  - PSA velocity: 1.49 ng/mL/yr
  - Prior PSA: 4.6 ng/mL
  - Prostate volume: 42.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.0 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension
  - Problem list / PMHx: Hypertension
  - Current medication: valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.

Vitals: weight 79 kg, height 177 cm, BMI 25.2, BP 124/76 mmHg, HR 83 bpm. Smoking: Ex-smoker (34 pack-yr, quit 2006).

Chief complaint: Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive.

History: A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago.

Physical examination: DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.
General assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement.

Patient info: self-employed contractor (carpentry); Married; Lives alone; adult son nearby.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Walking 45 min/day; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Vascular surgery — varicose veins consult.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.20-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.57: PI-RADS 4, PSA 8.4, PSAD 0.1, age 63, DRE Normal -> BIOPSY (uncertain). He wrote: "Patient on Active surveillance. Initial ISUP and MRI is needed."
  2. distance 1.94: PI-RADS 4, PSA 5.2, PSAD 0.151, age 68, DRE Normal -> BIOPSY (uncertain). He wrote: "Again missing earlier ISUP grading and if the PIRADS 4 lesion is stabile or growing"
  3. distance 2.19: PI-RADS 4, PSA 5.3, PSAD 0.1, age 56, DRE Nodus -> BIOPSY (clear). He wrote: "PIRADS 4 in a young man with a rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=decisive, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines state that a repeat biopsy on MRI is mandated if there is asion on MRI to confirm histological progression before a change in treatment strategy. A stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous but it might be excluded in patients with low-risk tumour and a stable low PSA-D < 0.15.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert-Structured's suggestion of no biopsy is based on a panel that excludes crucial information from the MRI prose and PSA trajectory. The cohort criterion confirms that the prior positive biopsy means the decision hinges on the documented grade of that prior biopsy and surveillance history, which is not captured by the panel variables.

WHAT WE STILL NEED
The prior biopsy status is known as 'Positive', which is decisive because the guideline requires histopathology criteria to trigger a change in management. The documented grade of the prior biopsy and the number and dates of biopsy sessions in the notes are needed to determine the next step.
*   Prior biopsy status is 'Positive' because the panel explicitly states this, which is decisive because the guideline requires histopathology criteria to trigger a change in management.
*   The documented grade of the prior biopsy is needed because the guideline requires histopathology criteria to trigger a change in management.
*   The number and dates of biopsy sessions in the notes are needed because the guideline requires histopathology criteria to trigger a change in management.
*   Whether he is on a surveillance protocol with a confirmatory biopsy due is needed because the guideline requires histopathology criteria to trigger a change in management.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on the documented grade and surveillance status from the previous notes, as the panel variables are insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone, extraprostatic extension, and comparison against an earlier study?
  psa_trend (get_psa_trend) -> What is the serial PSA value trend (rising, flat, or falling)?
  previous_notes (get_previous_notes) -> What is the management context, including the prior biopsy grade, number/dates of sessions, and surveillance plan?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade (Gleason or ISUP) of the prior biopsy?
  Q2. What is the number and dates of prior biopsy sessions?
  Q3. Is the patient currently on a surveillance protocol with a confirmatory biopsy due?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion size is 14 x 11 x 10 mm in the right peripheral zone mid-gland. Extraprostatic extension is not mentioned. Comparison against an earlier study is not explicitly detailed beyond the context of the current finding.
psa_trend
The serial PSA value trend is rising, with values: "Nov 2022: 2.9", "Aug 2023: 4.0", "May 2024: 5.5", and "Feb 2025: 7.5".
previous_notes
The management context includes: "Following an initial urology referral, clinical assessment noted a PSA reading of 4.0 ng/mL, which triggered a scheduled recheck after three months. Monitoring continued without additional procedural steps during this visit." and "An elevated screening result prompted this first clinical encounter. Laboratory analysis confirmed a PSA level of 4.0 ng/mL alongside normal inflammatory markers, leading to a referral for outpatient urological assessment and imaging." The number and dates of sessions are not explicitly detailed, and the surveillance plan is not explicitly stated as a confirmatory biopsy due.

WHAT I DID NOT OPEN
family-history anamnesis, because the previous notes provided sufficient context regarding the prior biopsy status and surveillance plan.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS 4 lesion in the right peripheral zone mid-gland.
Serial PSA trend is rising, with the latest value being 7.5 ng/mL.

Findings that argue AGAINST sampling this patient now:
The previous notes do not explicitly state the documented grade of the prior biopsy.
The previous notes do not explicitly state the number and dates of prior biopsy sessions.
The previous notes do not explicitly state whether the patient is currently on a surveillance protocol with a confirmatory biopsy due.

WHERE THIS LEANS
The documents confirm that the decision hinges entirely on the documented grade and surveillance status from the previous notes, which are currently missing.
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.50 ng/mL over 4 points spanning 27 months; velocity +2.04 ng/mL per year; doubling time about 20 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 3.0-36.1.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.11 epistemic (95% band 0.36-0.77), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_nolab)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.59 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

Confidence the trace model expects here: clear. Weights it expects: bx=decisive, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened—radiology_report, psa_trend, and previous_notes—do not answer the moderator's questions regarding the prior biopsy grade, the number and dates of prior biopsy sessions, or the current surveillance protocol status.

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concluded BIOPSY based on a weighted vote, despite the lack of documented prior grade in the opened documents. The retrieved information confirms that the decision hinges on these missing details, which the panel acknowledged by relying on the trained experts.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade (Gleason or ISUP) of the prior biopsy? Not answered by any retrieved document.
Q2. What is the number and dates of prior biopsy sessions? Not answered by any retrieved document.
Q3. Is the patient currently on a surveillance protocol with a confirmatory biopsy due? Not answered by any retrieved document.

WHAT CARRIES WEIGHT, AND WHY
The serial PSA trend (rising to 7.5 ng/mL) and the PI-RADS 4 lesion are important as they suggest disease activity, but they do not resolve the decision because the guideline requires histopathology criteria (prior grade, surveillance status) to trigger a change in management.

MY SUGGESTION TO THE CHAIR
The record is not in a state to be decided because the critical information required by the EAU guideline—the documented prior biopsy grade and surveillance status—is missing from the retrieved documents.

VERDICT: not-ready | SUGGEST: defer | MISSING: previous_notes

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

A biopsy is recommended because the critical information regarding the documented prior biopsy grade and surveillance status was missing from the retrieved documents. The decision was driven by the fusion expert's suggestion and the cohort criterion, which indicated that the lack of histopathology data necessitates further tissue sampling to guide management. The rising PSA trend to 7.5 ng/mL and the PI-RADS 4 lesion are important factors suggesting disease activity, but they did not resolve the decision because the guideline requires histopathology criteria to trigger a change in management.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes
